{
    "symbol": "ARGX",
    "slug": "argx",
    "display_name": "ARGX",
    "category": "stocks",
    "region": "EU",
    "description": null,
    "url": "https://finscans.com/asset/argx",
    "lang": "en",
    "as_of": "2026-06-28T03:35:08+00:00",
    "stats_30d": {
        "total_signals": 1,
        "bullish": 0,
        "bearish": 1,
        "neutral": 0,
        "explicit": 1,
        "inferred": 0,
        "avg_impact": 6,
        "avg_confidence": 70,
        "last_signal_at": "2026-06-08 10:51:18",
        "article_count": 1
    },
    "top_catalysts": [
        {
            "text": "Netherlands expands investment screening to biotech",
            "count": 1
        },
        {
            "text": "Increased regulatory risk for Dutch biotech acquisitions",
            "count": 1
        }
    ],
    "top_risk_factors": [
        {
            "text": "Argenx may have strong domestic or non-foreign funding",
            "count": 1
        },
        {
            "text": "Rules may not apply to existing investments",
            "count": 1
        }
    ],
    "recent_signals": [
        {
            "signal_at": "2026-06-08 10:51:18",
            "sentiment": "Bearish",
            "impact_score": 6,
            "confidence_score": 70,
            "mention_type": "explicit",
            "timeframe": "short-term",
            "region": "EU",
            "reasoning": "Argenx, a Dutch biotech company, faces new regulatory hurdles as the government expands investment screening to biotech. Foreign entities seeking to invest or acquire stakes in Argenx may now need government approval, creating uncertainty that could deter capital and delay partnerships.",
            "article": {
                "title": "Netherlands Tightens Foreign Investment Rules for AI and Biotech",
                "url": "https://finscans.com/news/netherlands-tightens-foreign-investment-rules-for-ai-and"
            }
        }
    ]
}